Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Date of authorisation: 11/02/2021, Revision: 17, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 23 May 2025 - 18:10

Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Date of authorisation: 11/02/2021, Revision: 17, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/retsevmo

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters